- Established in 1983
- Most valuable Pharma company in India
- Reported Turnover growth and profit growth of 10 times in last 10 years.
- Acquisition was the main ingredient of growth : Acquired 16 companies in last 20 years.
- Recent Acquisitions : TARO (Israel) in 2010, DUSA (US) in 2012, URL Pharma (US) in 2013, Ranbaxy (India) in April 2014.
- Zero debt and Rs.7500 Cr in cash balance gives further scope for acquisition.
- Derives 23% revenue in Indian branded generic market and 60% from US.
- 25 manufacturing facilities in 4 countries.
Thursday, August 28, 2014
Sun Pharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment